SCHEMBL18504037

SCHEMBL18504037

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4cccc(-c5cc(-c6cc(-c7ccccc7)cc(-c7ccccc7)n6)c6ccccc6n5)c4)c3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.51
ACACA Q13085 3/20 0.50
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 3/20 0.49
DHODH Q02127 1/20 0.49
KDM4E B2RXH2 3/20 0.47
PDE10A Q9Y233 1/20 0.47
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
TOP1 P11387 1/20 0.44
MAPK1 P28482 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504152 1.00 ACHE (0.51) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL13203069 0.98 ACHE (0.53) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL13203033 0.97 ACHE (0.54) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18503985 0.93 DHODH (0.52) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18504090 0.93 ACACA (0.48) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18504004 0.88 ACACA (0.59) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18504006 0.88 ACACA (0.55) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18504009 0.88 ACACA (0.55) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL18503950 0.88 ACACA (0.55) ACHEACACALMNASMN1; SMN2HPGD
SCHEMBL13203050 0.88 ACACA (0.58) ACHEACACALMNASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 ACHE 1742/4885ACACA 1286/4885LMNA 4643/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 ACHE 1742/4885ACACA 1286/4885LMNA 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.